financetom
LMNR
financetom
/
Consumer Staples
/
LMNR
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Limoneira CompanyLMNR
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Limoneira Company operates as an agribusiness and real estate development company in the United States and internationally.

The company operates through three divisions: Agribusiness, Rental Operations, and Real Estate Development.

It grows, processes, packs, markets, and sells lemons. The company also grows avocado, oranges, and specialty citrus and other crops, including Moro blood oranges, Cara Cara oranges, Valencia oranges, Minneola tangelos, Star Ruby grapefruit, pummelos, and wine grapes.

It has approximately 3,500 acres of lemons planted primarily in Ventura, Tulare, San Luis Obispo, and San Bernardino Counties in California; and Jujuy, Argentina, as well in Yuma County, Arizona, and La Serena, Chile; 1,200 acres of avocados planted in Ventura County; 100 acres of oranges planted in Tulare County, California; and 400 acres of specialty citrus and other crops.

In addition, the company rents residential housing units and commercial office buildings, as well as leases approximately 400 acres of its land to third-party agricultural tenants.

Further, it is involved in the organic recycling operations; and development of land parcels, multi-family housing, and single-family homes.

The company markets and sells its lemons directly to food service, wholesale, and retail customers; avocados, oranges, specialty citrus, and other crops to third-party packinghouses; and wine grapes to wine producers.

Limoneira Company was founded in 1893 and is headquartered in Santa Paula, California.

Latest News >
PepsiCo quarterly revenue misses estimates as demand slows for snacks, sodas
PepsiCo quarterly revenue misses estimates as demand slows for snacks, sodas
Jul 11, 2024
July 11 (Reuters) - PepsiCo ( PEP ) missed expectations for second-quarter revenue on Thursday as a series of price hikes and competition from private-label brands slowed sales of its snacks and soda mainly in the United States, its largest market. Analysts have said that product prices, which are starting to normalize almost after two years of multiple hikes, are...
Bitcoin Explodes Toward $60K as June CPI Numbers Favorable
Bitcoin Explodes Toward $60K as June CPI Numbers Favorable
Jul 11, 2024
The US Bureau of Labor Statistics (BLS) has published this months data for the Consumer Price Index. As is normally the case, this has caused some volatility within the cryptocurrency markets. In June, the CPI for all urban consumers fell 0.1%, seasonally adjusted This represents a change of 3% over the last 12 months, not seasonally adjusted. On the news,...
Akebia Regains Full Rights to Sell Vafseo Tablets in US After Ending Licensing Deal With CSL Vifor
Akebia Regains Full Rights to Sell Vafseo Tablets in US After Ending Licensing Deal With CSL Vifor
Jul 11, 2024
08:16 AM EDT, 07/11/2024 (MT Newswires) -- Akebia Therapeutics ( AKBA ) said Thursday that it has regained full rights to commercialize Vafseo tablets in the US after agreeing to terminate a license agreement with CSL Vifor. Akebia said it is now allowed to deal directly with all dialysis organizations effective immediately. Akebia said CSL Vifor is entitled to quarterly...
BRIEF-Johnson & Johnson Strengthens Pipeline to Lead in Atopic Dermatitis With the Completion of the Acquisition of Yellow Jersey Therapeutics, Gaining Ownership of NM26
BRIEF-Johnson & Johnson Strengthens Pipeline to Lead in Atopic Dermatitis With the Completion of the Acquisition of Yellow Jersey Therapeutics, Gaining Ownership of NM26
Jul 11, 2024
July 11 (Reuters) - Johnson & Johnson: * JOHNSON & JOHNSON STRENGTHENS PIPELINE TO LEAD IN ATOPIC DERMATITIS WITH THE COMPLETION OF THE ACQUISITION OF YELLOW JERSEY THERAPEUTICS, GAINING OWNERSHIP OF NM26 Source text for Eikon: Further company coverage: ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved